These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30416500)

  • 41. The antiviral immune response in mice devoid of immunoproteasome activity.
    Basler M; Beck U; Kirk CJ; Groettrup M
    J Immunol; 2011 Dec; 187(11):5548-57. PubMed ID: 22013127
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting Immunoproteasome in Polarized Macrophages Ameliorates Experimental Emphysema Via Activating NRF1/2-P62 Axis and Suppressing IRF4 Transcription.
    Guo B; Shi X; Jiang Q; Pan Y; Yang Y; Liu Y; Chen S; Zhu W; Ren L; Liang R; Chen X; Xu H; Wei L; Lin Y; Wang J; Qiu C; Zhou H; Rao L; Wang L; Chen R; Chen S
    Adv Sci (Weinh); 2024 Oct; ():e2405318. PubMed ID: 39356034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF-κB activation.
    Bitzer A; Basler M; Krappmann D; Groettrup M
    Mol Immunol; 2017 Mar; 83():147-153. PubMed ID: 28157553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells.
    Marienfeld R; Neumann M; Chuvpilo S; Escher C; Kneitz B; Avots A; Schimpl A; Serfling E
    Eur J Immunol; 1997 Jul; 27(7):1601-9. PubMed ID: 9247567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PR-957, a selective inhibitor of immunoproteasome subunit low-MW polypeptide 7, attenuates experimental autoimmune neuritis by suppressing T
    Liu H; Wan C; Ding Y; Han R; He Y; Xiao J; Hao J
    FASEB J; 2017 Apr; 31(4):1756-1766. PubMed ID: 28096232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of B cell-mediated T cell costimulation in the efficacy of the T cell retargeting bispecific antibody BIS20x3.
    Stel AJ; Kroesen BJ; Jacobs S; Groen H; de Leij LF; Kluin-Nelemans HC; Withoff S
    J Immunol; 2004 Nov; 173(10):6009-16. PubMed ID: 15528335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10.
    Lobry C; Lopez T; Israël A; Weil R
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):908-13. PubMed ID: 17213322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Noncytotoxic Inhibition of the Immunoproteasome Regulates Human Immune Cells In Vitro and Suppresses Cutaneous Inflammation in the Mouse.
    Ah Kioon MD; Pierides M; Pannellini T; Lin G; Nathan CF; Barrat FJ
    J Immunol; 2021 Apr; 206(7):1631-1641. PubMed ID: 33674446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proteasome inhibition profoundly affects activated human B cells.
    Mulder A; Heidt S; Vergunst M; Roelen DL; Claas FH
    Transplantation; 2013 Jun; 95(11):1331-7. PubMed ID: 23624544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1/2 pathway.
    Cheng Y; Zhu Y; Xu J; Yang M; Chen P; Xu W; Zhao J; Geng L; Gong S
    Mol Cancer; 2018 Jan; 17(1):13. PubMed ID: 29368606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of proteasomes in T cell activation and proliferation.
    Wang X; Luo H; Chen H; Duguid W; Wu J
    J Immunol; 1998 Jan; 160(2):788-801. PubMed ID: 9551914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dual specificity phosphatase DUSP6 promotes endothelial inflammation through inducible expression of ICAM-1.
    Hsu SF; Lee YB; Lee YC; Chung AL; Apaya MK; Shyur LF; Cheng CF; Ho FM; Meng TC
    FEBS J; 2018 May; 285(9):1593-1610. PubMed ID: 29493888
    [TBL] [Abstract][Full Text] [Related]  

  • 53. T cells lacking immunoproteasome subunits MECL-1 and LMP7 hyperproliferate in response to polyclonal mitogens.
    Caudill CM; Jayarapu K; Elenich L; Monaco JJ; Colbert RA; Griffin TA
    J Immunol; 2006 Apr; 176(7):4075-82. PubMed ID: 16547243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Critical role of the calpain/calpastatin balance in acute allograft rejection.
    Letavernier E; Dansou B; Lochner M; Perez J; Bellocq A; Lindenmeyer MT; Cohen CD; Haymann JP; Eberl G; Baud L
    Eur J Immunol; 2011 Feb; 41(2):473-84. PubMed ID: 21268016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase.
    Ruefli-Brasse AA; French DM; Dixit VM
    Science; 2003 Nov; 302(5650):1581-4. PubMed ID: 14576442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BCL11B enhances TCR/CD28-triggered NF-kappaB activation through up-regulation of Cot kinase gene expression in T-lymphocytes.
    Cismasiu VB; Duque J; Paskaleva E; Califano D; Ghanta S; Young HA; Avram D
    Biochem J; 2009 Jan; 417(2):457-66. PubMed ID: 18831712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low Neurotoxicity of ONX-0914 Supports the Idea of Specific Immunoproteasome Inhibition as a Side-Effect-Limiting, Therapeutic Strategy.
    von Brzezinski L; Säring P; Landgraf P; Cammann C; Seifert U; Dieterich DC
    Eur J Microbiol Immunol (Bp); 2017 Sep; 7(3):234-245. PubMed ID: 29034113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of zeta PKC in B-cell signaling and function.
    Martin P; Duran A; Minguet S; Gaspar ML; Diaz-Meco MT; Rennert P; Leitges M; Moscat J
    EMBO J; 2002 Aug; 21(15):4049-57. PubMed ID: 12145205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteasome or immunoproteasome inhibitors cause apoptosis in human renal tubular epithelial cells under normoxic and hypoxic conditions.
    Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
    Int Urol Nephrol; 2016 Jun; 48(6):907-15. PubMed ID: 26920131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
    Delgado M; Ganea D
    J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.